These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6146975)

  • 21. [Salazosulfapyridine in rheumatoid arthritis. A study of 49 patients].
    Hilliquin P; Munoz A; Menkes CJ
    Ann Med Interne (Paris); 1992; 143(3):149-54. PubMed ID: 1355956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization to sulfasalazine after hypersensitivity reactions in patients with inflammatory bowel disease.
    Korelitz BI; Present DH; Rubin PH; Fochios SE
    J Clin Gastroenterol; 1984 Feb; 6(1):27-31. PubMed ID: 6142067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. False-positive Waaler-Rose test in IgA deficiency.
    Hammarström L; Smith CI
    Scand J Rheumatol; 1985; 14(1):83-4. PubMed ID: 2860720
    [No Abstract]   [Full Text] [Related]  

  • 24. Salazopyrine-induced aseptic meningitis.
    Houitte R; Abgueguen P; Masson C
    Joint Bone Spine; 2009 Mar; 76(2):216-7. PubMed ID: 19217336
    [No Abstract]   [Full Text] [Related]  

  • 25. Side-effects of salazopyrin on male fertility.
    Steeno OP
    Eur J Obstet Gynecol Reprod Biol; 1984 Dec; 18(5-6):361-4. PubMed ID: 6151915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
    Petkov T; Pehlivanov G; Grozdev I; Kavaklieva S; Tsankov N
    Eur J Dermatol; 2007; 17(5):422-7. PubMed ID: 17673387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pyoderma gangrenosum: treatment by salazosulfapyridine].
    Schmutz JL; Bartin RH; Thess F; Weber M; Beurey J
    Ann Dermatol Venereol; 1987; 114(6-7):869-70. PubMed ID: 2890322
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of rheumatoid polyarthritis with salazosulfapyridine].
    Nolla JM; Fiter J; Mateo L
    Rev Rhum Mal Osteoartic; 1992 Jan; 59(1):84. PubMed ID: 1349766
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulphasalazine desensitisation.
    Holdsworth CD
    Br Med J (Clin Res Ed); 1981 Jan; 282(6258):110. PubMed ID: 6109553
    [No Abstract]   [Full Text] [Related]  

  • 30. [40 years of salazosulfapyridine. Is end in sight?].
    van Hees PA; van Tongeren JH
    Ned Tijdschr Geneeskd; 1982 Oct; 126(44):2014-8. PubMed ID: 6129576
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hypersensitivity reaction to sulfasalazine with a clinical picture similar to mononucleosis].
    Foresti V; Tronci M; Ungaro A; Confalonieri F
    Recenti Prog Med; 1988 Sep; 79(9):382-3. PubMed ID: 2904684
    [No Abstract]   [Full Text] [Related]  

  • 32. The treatment of 124 cases of ulcerative colitis with salazopyrine and attempts of desensibilization in cases of hypersensitiveness to sulfa.
    SVARTZ M
    Acta Med Scand; 1948; 131(Suppl 206):465-72. PubMed ID: 18881171
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmachem's salazopyrine in rheumatoid arthritis].
    Konstantinova M; Konstantinova V
    Vutr Boles; 1990; 29(5):65-8. PubMed ID: 1981958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [DRESS syndrome].
    Khaled A; Souissi A; Zeglaoui F; El Fekih N; Daghfous R; Fazaa B
    Tunis Med; 2012 Oct; 90(10):749-51. PubMed ID: 23096521
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to sulfasalazine.
    Ribe J; Benkov KJ; Thung SN; Shen SC; LeLeiko NS
    Am J Gastroenterol; 1986 Mar; 81(3):205-8. PubMed ID: 2869683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulfasalazine hypersensitivity with hepatotoxicity, thrombocytopenia, and erythroid hypoplasia.
    Gremse DA; Bancroft J; Moyer MS
    J Pediatr Gastroenterol Nutr; 1989 Aug; 9(2):261-3. PubMed ID: 2572687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfasalazine. Adverse effects and desensitization.
    Taffet SL; Das KM
    Dig Dis Sci; 1983 Sep; 28(9):833-42. PubMed ID: 6136396
    [No Abstract]   [Full Text] [Related]  

  • 38. The safety of sulfasalazine: the gastroenterologists' experience.
    Sachar DB
    J Rheumatol Suppl; 1988 Sep; 16():14-6. PubMed ID: 2903923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic granulomatous disease of childhood: gastric manifestation and response to salazosulfapyridine therapy.
    Stopyrowa J; Fyderek K; Sikorska B; Kowalczyk D; Zembala M
    Eur J Pediatr; 1989 Oct; 149(1):28-30. PubMed ID: 2575030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New salazosulfapyridine derivatives. Progress in the treatment of chronic inflammatory diseases of the intestines?].
    Modigliani R; Rambaud JC
    Gastroenterol Clin Biol; 1987 Apr; 11(4):325-32. PubMed ID: 2884162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.